Mirikizumab成功地解决了UC的活动性组织学炎症

{"title":"Mirikizumab成功地解决了UC的活动性组织学炎症","authors":"S. Kammerer","doi":"10.55788/abaaf5dd","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":119347,"journal":{"name":"Medicom Conference Report UEGW 2022","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mirikizumab successfully resolves active histologic inflammation in UC\",\"authors\":\"S. Kammerer\",\"doi\":\"10.55788/abaaf5dd\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":119347,\"journal\":{\"name\":\"Medicom Conference Report UEGW 2022\",\"volume\":\"80 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report UEGW 2022\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/abaaf5dd\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report UEGW 2022","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/abaaf5dd","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}